Research primarily has demonstrated that COX-2 is up-regulated in a range of cancers, particularly colorectal cancer [3], but also gastric [5], breast [8], thyroid [9], and ovarian cancers [10–12]. The gene discussed is PTGS2; the disease is cancer.